Eisai
4523.T
#2094
Rank
NZ$15.83 B
Marketcap
NZ$56.16
Share price
-0.39%
Change (1 day)
25.09%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.52. an increase over its 2024 EPS that were of NZ$1.71.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$1.9211.85%
2024NZ$1.71-32.63%
2023NZ$2.545.52%
2022NZ$2.41-74.01%
2021NZ$9.27-66.58%
2020NZ$27.7498.24%
2019NZ$13.9917.01%
2018NZ$11.9637.78%
2017NZ$8.68-27.62%
2016NZ$11.9935.33%
2015NZ$8.86-2.82%
2014NZ$9.12-27.66%
2013NZ$12.61-27.49%
2012NZ$17.39-12.67%
2011NZ$19.9188.08%
2010NZ$10.59-11.06%
2009NZ$11.90-390.15%
2008NZ-$4.10-127.78%
2007NZ$14.7711.78%
2006NZ$13.214.38%
2005NZ$12.667.4%
2004NZ$11.7943.03%
2003NZ$8.2425.09%
2002NZ$6.5952.67%
2001NZ$4.3269.76%
2000NZ$2.54